{
    "title": "AnaptysBio's skin disease drug meets main goal in late-stage study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12610597/AnaptysBios-skin-disease-drug-meets-main-goal-late-stage-study.html",
    "date": "2023-10-09",
    "keywords": [
        "drug",
        "disease",
        "study",
        "psoriasis",
        "company",
        "inc",
        "monday",
        "type",
        "goal",
        "latestage",
        "condition",
        "developer",
        "marketing",
        "application",
        "imsidolimab",
        "food",
        "administration",
        "quarter",
        "safety",
        "gpp",
        "skin",
        "body",
        "fever",
        "pain",
        "development",
        "autoimmune",
        "inflammatory",
        "portfolio",
        "anaptysbio",
        "trading",
        "reporting",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}